Your browser doesn't support javascript.
loading
An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.
Durlacher, Cameron T; Li, Zhi-Ling; Chen, Xiao-Wu; He, Zhi-Xu; Zhou, Shu-Feng.
Afiliação
  • Durlacher CT; Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.
  • Li ZL; Department of Pharmacy, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Chen XW; Department of General Surgery, The First People's Hospital of Shunde Affiliated to Southern Medical University, Shunde, Foshan, Guangdong.
  • He ZX; Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Centre & Sino-US Joint Laboratory for Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
  • Zhou SF; Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.
Clin Exp Pharmacol Physiol ; 43(6): 585-601, 2016 06.
Article em En | MEDLINE | ID: mdl-26999067
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Aurora Quinase A / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Clin Exp Pharmacol Physiol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Aurora Quinase A / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Clin Exp Pharmacol Physiol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos